These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 23247537)

  • 1. The relation between bone and stone formation.
    Krieger NS; Bushinsky DA
    Calcif Tissue Int; 2013 Oct; 93(4):374-81. PubMed ID: 23247537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.
    Frick KK; Krieger NS; Bushinsky DA
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):336-44. PubMed ID: 26050120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK; Asplin JR; Krieger NS; Culbertson CD; Asplin DM; Bushinsky DA
    Am J Physiol Renal Physiol; 2013 Oct; 305(8):F1132-8. PubMed ID: 23926184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK; Asplin JR; Culbertson CD; Granja I; Krieger NS; Bushinsky DA
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1081-7. PubMed ID: 24573387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.
    Ng AH; Frick KK; Krieger NS; Asplin JR; Cohen-McFarlane M; Culbertson CD; Kyker-Snowman K; Grynpas MD; Bushinsky DA
    Calcif Tissue Int; 2014 May; 94(5):531-43. PubMed ID: 24481706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Frick KK; Nehrke K
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):403-18. PubMed ID: 16775455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Calcium Absorption among Hypercalciuric Patients with or without Calcium Kidney Stones.
    Vezzoli G; Macrina L; Rubinacci A; Spotti D; Arcidiacono T
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1450-1455. PubMed ID: 27284011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.
    Frick KK; Asplin JR; Favus MJ; Culbertson C; Krieger NS; Bushinsky DA
    Am J Physiol Renal Physiol; 2013 Mar; 304(6):F718-26. PubMed ID: 23344574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
    Bushinsky DA; Neumann KJ; Asplin J; Krieger NS
    Kidney Int; 1999 Jan; 55(1):234-43. PubMed ID: 9893132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic hypercalciuric stone-forming rats have a primary decrease in BMD and strength.
    Grynpas M; Waldman S; Holmyard D; Bushinsky DA
    J Bone Miner Res; 2009 Aug; 24(8):1420-6. PubMed ID: 19257830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Laplante K; Asplin JR
    Kidney Int; 2006 May; 69(9):1586-92. PubMed ID: 16557225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats.
    Krieger NS; Stathopoulos VM; Bushinsky DA
    Am J Physiol; 1996 Jul; 271(1 Pt 1):C130-5. PubMed ID: 8760038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Willett T; Asplin JR; Culbertson C; Che SP; Grynpas M
    J Bone Miner Res; 2011 Aug; 26(8):1904-12. PubMed ID: 21351146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium Decreases Urine Supersaturation but Not Calcium Oxalate Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.
    Li Q; Krieger NS; Yang L; Asplin J; Bushinsky DA
    Nephron; 2024; 148(7):480-486. PubMed ID: 38262368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results].
    Moyano MJ; Gómez de Tejada MJ; García Lozano R; Moruno R; Ortega R; Martí V; Sánchez Palencia R; Miranda MJ; Palma A; Pérez Cano R
    Nefrologia; 2007; 27(6):694-703. PubMed ID: 18336098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail.
    Bai S; Wang H; Shen J; Zhou R; Bushinsky DA; Favus MJ
    J Bone Miner Res; 2010 Apr; 25(4):830-40. PubMed ID: 19929616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.